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a  b  s  t  r  a  c  t
Launaea  procumbens  Linn.  is a  plant  commonly  found  in  the  west  India  and  has  been
reported  to decrease  the  renal  calculi.  This  study  investigated  the  anti-urolithiatic  activ-
ity of  L.  procumbens  against  ethylene  glycol-induced  urolithiasis  and  its  possible  underlying
mechanisms.  The  crude  methanolic  extract  of  L. procumbens  leaves  was studied  using  ethyl-
ene glycol-induced  renal  calculi  in  rat  model.  Results  indicate  that  ethylene  glycol  feeding
to rats  resulted  in  to hyper  oxaluria,  hypercalciuria,  as well  as  increased  renal  excretion
of  phosphate.  Supplementation  with  methanolic  extract  of L.  procumbens  leaves  (MELP)
signiﬁcantly  prevented  changes  in  urinary  calcium,  oxalate  and  phosphate  excretion  dose-
dependently.  The  increased  calcium  and  oxalate  level  and  number  of  calcium  oxalate  crystal
in the kidney  tissue  of  calculogenic  rats  were  signiﬁcantly  reverted  by  supplementation
with  MELP.  The  MELP  supplementation  also  prevents  the  impairment  of  renal  functions.
The  mechanism  underlying  this  effect  is  mediated  possibly  through  antioxidant  nephro-
protection  and  its  effect  on urinary  concentration  of  stone  forming  constituents  and  risk
factor.
Conclusion:  These  results  indicate  that  methanolic  extracts  of  L.  procumbens  leaves  are
effective against  the  urolithiasis.
© 2014  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under
Y-NC-Nthe CC  B
1. Introduction
Kidney stone disease is a multi-factorial disorder result-
ing  from the combined inﬂuence of epidemiological,
biochemical and genetic risk factors. It occurs both in men
and  women but the risk is generally higher in men  and is
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becoming more common in young women [16]. Surgical
operation, lithotripsy and local calculus disruption using
high-power laser are widely used to remove the calculi.
However, these procedures are expensive and recurrence
is  also common [14]. The recurrence rate without preven-
tive  treatment is approximately 10% at 1 year, 33% at 5 years
and  50% at 10 years [4]. Various therapies including thiazide
diuretics and alkali-citrate are being used in attempt to pre-
vent  recurrence but scientiﬁc evidence for their efﬁcacy is
less  convincing [2].
In  the traditional systems of medicine including
Ayurveda, most of the remedies were taken from plants
and  they were proved to be useful though the rationale
is is an open access article under the CC BY-NC-ND license
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ehind their use is not well established through sys-
ematic pharmacological and clinical studies except for
ome  composite herbal drugs and plants. These plant
roducts are reported to be effective in decreasing the
ecurrence rate of renal calculi with no side effects
14].
As per the indigenous system of medicine, the leaves
f  Launaea procumbens Linn. were reported to be use-
ul  in the treatment of a wide range of aliments
ncluding urinary stones [11,18]. However, so far no
cientiﬁc study has been reported regarding the anti-
rolithiatic activity of methanolic extract of L. procumbens
eaves (MELP). In this study, we investigated evalua-
ion for the anti-urolithiatic activity of L. procumbens
gainst ethylene glycol-induced renal calculi and its pos-
ible  underlying mechanisms using male Wistar albino
ats.
.  Materials and methods
.1.  Plant material and preparation of extract
The leaves of L. procumbens were collected from the
ocal area of Saurashtra University, Rajkot in the month
f  August and shade dried. The plant was authenticated
y Dr. A.S. Reddy, Sardar Patel University, Vallabh Vid-
yanagar, Gujarat and a voucher specimen was deposited
n  the herbarium of the Department of Pharmaceutical
ciences, Saurashtra University, Rajkot for future refer-
nce.  The dried leaves were coarsely powdered (passed
hrough sieve no. 40) and packed in to the Soxhlet col-
mn  and extracted with 95% (v/v) methanol at 40–45 ◦C
or  24 h. The extract obtained was evaporated at 45 ◦C,
hen  dried and stored in airtight container (yield 27.69%,
/w).
.2.  Chemicals and apparatus
Ethylene  glycol was purchased from Merck Ltd., Mum-
ai,  India. Various kits for biochemical estimation of
rine  and serum were purchased from Span Diagnos-
ics, Mumbai, India. All other chemicals and reagents
sed were analytical grade and procured from approved
hemical suppliers. Apparatus such as the metabolic cage
INCO,  Ambala, India), semiautoanalyzer (model Microlab-
00,  Merck, Germany), cold centrifuge (Remi, compufuge,
orea), UV-spectrometer (model UV 1800, Shimadzu,
apan) were used in the study.
.3. Animals
Male Wistar albino rats (8 weeks old having body
eight 150–200 g) were used for the present study. They
ere  housed in polypropylene cages (ﬁve per cage) and
aintained under temperature (27 ± 2 ◦C) and light (12 h
ight/dark  cycles; lights on at 0700 h) controlled envi-
onment. The animals were given standard diet (Amrut,
ranav Agro Ind Ltd., Vadodara, India). The study proto-
ol  was approved (approval no. SU/DPS/IAEC/2011/13) by
he  Institutional Animal Ethics Committee constituted in
ccordance with the rules and guidelines of the Committeeeports 1 (2014) 46–52 47
for  the Purpose of Control and Supervision of Experi-
ments on Animals, Ministry of Environment and Forest,
India.
2.4.  Ethylene glycol-induced urolithiasis model in rats
Urolithiasis was induced by ethylene glycol and ammo-
nium chloride in experimental animals [5,9]. Brieﬂy, thirty
animals  were randomly divided into ﬁve groups (n = 6) as
follow:
Group  I: Vehicle Control group; received 0.5% (w/v) gum
acacia solution (5 ml/kg p.o.) and maintained on regular
rat food and drinking water ad libitum for 21 days
Group II: Ethylene glycol (EG) group; received 0.75% (v/v)
EG in drinking water alone for 21 days
Group III: Cystone group; received standard drug cystone
(750 mg/kg, p.o.) for 21 days
Groups IV and V: Treatment group; fed orally with
methanolic extract of L. procumbens leaves (MELP) 150 and
300 mg/kg, respectively, for 21 days
Groups II–V received urolithiasis inducing treatment
(0.75%, v/v ethylene glycol in drinking water) for 21 days.
Further, ammonium chloride (1%, w/v  in drinking water)
was co-administered with EG for the ﬁrst 3 days in order
to augment lithiasis effect of EG.
2.5.  Collection and analysis of urine
All animals were kept in individual metabolic cages and
24  h urine samples were collected on 0, 7, 14, 21st day of
calculi  induction treatment period. The volume of urine
was  measured and calcium content estimated by diagnostic
kit  (Span Diagnostics Pvt. Ltd., India) in clinical semiau-
toanalyser. Various urine parameters such as oxalate [8],
magnesium [7,12], phosphate [6], uric acid [20], and total
protein  [21] were performed as per the manuals provided
with various kits.
2.6.  Serum analysis
The  blood was  collected from the retro-orbital sinus
under anaesthetic condition (diethyl ether used for anaes-
thesia)  and serum was  separated by centrifugation at
10,000  × g for 10 min  and analyzed for creatinine and uric
acid.  The creatinine kit (Span Diagnostics Pvt. Ltd., India)
and  uric acid diagnostic kit (Span Diagnostics Ltd., India)
were  used to estimate serum creatinine and uric acid levels
respectively.
2.7.  Kidney histopathological study
Histopathological study of kidney was followed as per
the  method of K. Divakar et al. (2010). Brieﬂy, the abdomen
was  cut open to isolate both kidneys from each animal. Iso-
lated  kidneys were then cleaned off extraneous tissue and
rinsed  in ice-cold physiological saline. The right kidney was
ﬁxed  in 10% neutral buffered formalin, processed in a series
of  graded alcohol and xylene, embedded in parafﬁn wax,
sectioned at 5 m and stained with haematoxylin (H) and
eosin  (E) for histopathological examination. The slides were
icology R48 A. Makasana et al. / Tox
examined under light microscope (magniﬁcation 10×) to
study  light microscopic architecture of the kidney and cal-
cium  oxalate deposits. The left kidney was ﬁnely minced
and  20% homogenate was prepared in Tris–HCl buffer
(0.02 mol/l, pH 7.4). Total kidney homogenate was used for
assaying  tissue calcium, oxalate [8] and lipid peroxidation
activity [17].
2.8.  Statistical analysis
The  results are expressed as mean ± SEM. The statistical
signiﬁcance was assessed using One-way Analysis of Vari-
ance  (ANOVA) followed by Dunnett’s multiple comparison
test and value of p < 0.05 was considered signiﬁcant.
3. Results
3.1. Urine analysis
The  urinary output was increased signiﬁcantly (p < 0.01)
in  calculi-induced rats. The urinary output of the vehi-
cle  treated group was 5.68 ± 0.91 ml/day/rat on the 21st
day,  which was  increased to about 212.32% in renal stone
induced Group II. In the prophylactic groups, the urine out-
put  was lower than that of the calculi-induced rats but
signiﬁcantly higher than vehicle treated rats (Table A1).
Urinary  calcium, and magnesium excretion was
decreased by stone inducing treatment group. However,
supplementation with MELP signiﬁcantly prevented these
changes  (Table A2).
In  the present study, renal stone inducing treatment
to male Wistar rats resulted in hyperoxaluria. There was
an  increase in oxalate phosphate and uric acid excre-
tion in Group II. However, supplementation with MELP
signiﬁcantly prevented these changes in urinary oxalate,
phosphate and uric acid excretion dose-dependently in
Groups  IV and V (Table A3).
3.2. Kidney homogenate analysis
Renal stone induction caused signiﬁcant increase
(p < 0.01) in lipid peroxidation of kidney tissue of the Group
II  (Table A4), which was dose-dependently prevented in
the  animals receiving 150 and 300 mg/kg treatment with
MELP.
The  deposition of the calcium in the renal tissue
was increased in the Group II (Table A4). However, 150
and  300 mg/kg doses of methanolic extract signiﬁcantly
(p < 0.01) reduced the increase of calcium in renal tissue in
prophylactic groups, whereas, only 300 mg/kg of methano-
lic  extract in prophylactic group signiﬁcantly (p < 0.01)
reduced the elevation of renal calcium content.
3.3. Serum analysis
Renal  stone induction caused impairment of renal func-
tion  of the untreated rats as was evident from the markers
of  glomerular and tubular damage: elevated serum creati-
nine,  uric acid and also urinary protein loss (p < 0.01), which
were  dose-dependently prevented in the animals receivingeports 1 (2014) 46–52
a  simultaneous treatment with MELP at dose of 150 mg/kg
and  300 mg/kg (Tables A4 and A5).
3.4. Kidney histopathology
Histopathological analysis revealed no calcium oxalate
deposits or other abnormalities in the nephron segments
of  vehicle treated group. On the other hand, many calcium
oxalate deposits inside the renal tubules and dilation of
the  proximal tubules along with interstitial inﬂammation
were observed in the renal tissue of urolithiatic rats. The
number of calcium oxalate deposits in the renal tubules of
Groups  IV and V rats was  signiﬁcantly less than the Group
II  (Fig. B1).
4.  Discussion
As traditional medicines are usually taken by the oral
route, same route of administration was used for evaluation
of  antiurolithiatic activity of L. procumbens against ethylene
glycol  induced renal calculi in rats.
Male rats were selected to induce urolithiasis because
the urinary system of male rats resembles that of humans
and  earlier studies have shown that kidney stone for-
mation in female rats was  signiﬁcantly less than male
rats  [9] The phytochemical studies of MELP showed
the presence of alkaloids, glycosides, ﬂavonoids, tannins,
anthraquinones, ﬁxed oils and fats, carbohydrates, ter-
penoids and steroids.
Urinary  super saturation with respect to stone-forming
constituents is generally considered to be one of the
causative factors in calculogenesis. Previous studies indi-
cated  that upon 14 days administration of ethylene glycol
to  young albino rats resulted into the formation of renal
calculi composed mainly of calcium oxalate. The biochem-
ical  mechanism for this process is related to an increase
in  the urinary concentration of oxalate. Stone formation
in  ethylene glycol fed rats is caused by hyperoxaluria,
which causes increased renal retention and excretion
of oxalate [9]. Renal calcium oxalate deposition by EG
(ethylene glycol) and ammonium chloride in rats is fre-
quently used to mimic  the urinary stone formation in
humans. Ammonium chloride reported to accelerate the
lithiaisis  [1,5]. Therefore, this model was  used to evaluate
the  protective effect of L. procumbens against urolithia-
sis.
Urinary chemistry is one of the important factors in
determining the type of crystal formed and the nature of
macromolecules included on the surface of the crystals.
Hence, the study of the urinary chemistry related to the
calculi  forming minerals will provide a good indication of
the  extent of stone formation.
Consistent  with some previous reports [2], stone induc-
tion  by EG caused an increase in oxalate and decrease in
calcium  urinary excretion in the Group II. Calcium excre-
tion  was  reduced by MELP treatment in a dose-dependent
manner compared with Group II.Normal urine contains many inorganic and organic
inhibitors of crystallization, magnesium is one such well-
known  inhibitors. Low levels of magnesium are also
encountered in stone formers as well as in stone-forming
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ats. The magnesium levels return to normal on drug treat-
ent  [16]. Diets enriched with high magnesium have been
ound  to protect against deposition of calcium oxalate in
he  kidneys of vitamin B6 deﬁcient rats. Promising results
n  preventing recurrence have been shown in patients
reated with potassium magnesium citrate. Magnesium
omplexes with oxalate and reduce the super saturation
f  calcium oxalate by reducing the saturation of calcium
xalate and as a consequence reduces the growth and
ucleation rate of calcium oxalate crystals [16,19]. Urinary
agnesium was signiﬁcantly diminished in ethylene gly-
ol  induced urolithic rats. The MELP treatment restored
he magnesium excretion compared to EG treatment
roup.
An increase in urinary phosphorus excretion was
bserved in ethylene glycol induced urolithic rats.
ncreased excretion of phosphorus has been reported in
tone  formers [19]. Increased urinary phosphorus excre-
ion  along with oxalate stress seems to provide an
nvironment appropriate for stone formation by forming
alcium phosphate crystals, which epitaxially induces cal-
ium  oxalate deposition [9,16,19].
The increase in urinary uric acid excretion was observed
n  urolithic rats. Increased excretion of uric acid has been
eported in stone formers and hyper oxaluric rats. Uric acid
nterferes  with calcium oxalate solubility and it binds and
educes  the inhibitory activity of glycosaminoglycans [16].
he  predominance of uric acid crystals in calcium oxalate
tones and the observation that uric acid binding proteins
re  capable of binding to calcium oxalate and modulate
ts crystallization also suggests its primary role in stone
ormation [16,19].
The  present observation showed increased protein
xcretion in ethylene glycol induced urolithic rats [16,19].
roteinuria reﬂects proximal tubular dysfunction. Super-
aturation of urinary proteins results in precipitation as
rystal  initiation particle which when trapped acts as a
idus  leading to subsequent crystal growth. This is asso-
iated  with proteinuria [16]. Administration of MELP had
rofound  effects on minimizing the excretion of protein in
roup  IV and thus might have prevented the nidus forma-
ion  for crystal nucleation.
In  urolithiasis, the glomerular ﬁltration rate decreases
ue to the obstruction to the ﬂow of urine by stones in
rinary system. So, the waste products particularly nitroge-
ous  substances such as urea, creatinine and uric acid
ccumulate in blood. Also, increased lipid peroxidation
nd decreased levels of antioxidant potential have been
eported in the kidneys of rats supplemented with a calculi-
roducing diet. Elevated oxalate concentration in urine has
een  reported to induce lipid peroxidation and cause renal
amage  by reacting with polyunsaturated fatty acids in cell
embrane  [9]. In calculi-induced rats, marked renal dam-
ge  was seen as indicated by the elevated serum levels of
reatinine and uric acid which are markers of glomerular
nd tubular damage. Treatment of MELP showed to prevent
he  elevation of serum levels of these markers and inhibits
he  lipid peroxidation.
Increase in calcium levels in the renal tissue of EG
reated rats was observed. The MELP treatment sup-
resses this increase in intracellular calcium. The exacteports 1 (2014) 46–52 49
reason  of this effect is not clear, however it might be
due  to the increased bioavailability of NO (nitric oxide)
which in turns activates cGMP (3′,5′ cyclic guanosine
monophosphate) that controls the increase in intracel-
lular calcium levels. Previous studies reported that NO
donors  have the capacity to control the intracellular rise
in  calcium levels. Thus, plant extract could effectively con-
trol  the levels of both the salts by the mechanism such
as  inhibiting the oxalate or increasing the bioavailability
of NO to sequester calcium through the cGMP pathway
[15].
Microscopic examination of kidney sections derived
from ethylene glycol induced-urolithic rats showed poly-
morphic  irregular crystal deposits inside the tubules which
cause  dilation of the proximal tubules along with inter-
stitial  inﬂammation that might be attributed to oxalate.
Co-treatment with the MELP decreased the number and
size  of calcium oxalate deposits in different parts of the
renal  tubules and also prevented damages to the tubules
and  calyxes.
5.  Conclusion
The current study was able to show the antiurolithi-
atic effect of leaf extract of L. procumbens in ethylene
glycol induced renal calculi model. Therefore, MELP may
prevent  calcium oxalate crystal deposition in the kid-
ney  by preventing hyperoxaluria-induced peroxidative
damage to the renal tubular membrane surface (lipid per-
oxidation), which in turn can prevent calcium oxalate
crystal attachment and subsequent development of kidney
stones.
Also,  these results indicate administration of leaf extract
of  L. procumbens reduced and prevented the growth of
urinary stones. Earlier study reported that L. procumbens
is useful in renal disorder amelioration (RA. et al., 2010).
Therefore, the leaf extract of L. procumbens is helpful to pre-
vent  the recurrence of the disease as it showed its effect on
early  stages of stone development.
The  mechanism underlying this effect is possibly
mediated through antioxidant nephroprotective prop-
erties  and also lowering the concentration of urinary
stone-forming constituents. However, it requires more
investigation to clarify the exact mechanism of this
action.
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Appendix A.
Fig. B1. Histopathology of kidney tissue of (A) vehicle control, (B) calculi induced group, crystal of calcium oxalate shown in the box (C) cystone treated,
(D)  prophylactic treatment with MELP at the dose 150 mg/kg, (E) prophylactic treatment with MELP at the dose 300 mg/kg. Microscopic magniﬁcation:
40×.
Table A1
Effect  of methanolic extract of Launaea procumbens leaves on urinary output (ml/24 h) of different groups of rat.
Days Group I Group II Group III Group IV Group V
0 7.38 ± 0.87 7.50 ± 0.34 4.67 ± 0.44a**b** 7.83 ± 0.48 8.00 ± 0.37
7  9.31 ± 0.11b** 12.36 ± 0.42a** 10.42 ± 0.40 9.00 ± 0.52b** 13.17 ± 0.70a***
14 7.723 ± 0.39a*** 17.56 ± 1.77a*** 17.69 ± 0.50a*** 10.66 ± 0.50 13.56 ± 0.76a***
21 8.77 ± 0.65b*** 17.74 ± 1.13a*** 17.98 ± 0.86a*** 11.65 ± 0.67b*** 13.74 ± 0.54a***b**Values are expressed in ml/24 h urine volume as mean ± SEM (n = 6). One-way Ana
Group  I: Vehicle control, Group II: EG group, Group III: Cystone group, Group IV:
group.  Comparisons are made against Group I (vehicle control)a and Group II (lith
** p < 0.01.
*** p < 0.001.lysis of Variance (ANOVA) followed by multiple comparison Dunnett test.
 150 mg/kg MELP treatment group, Group V: 300 mg/kg MELP treatment
iatic control)b.
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Table A2
Effect of methanolic extract of Launaea procumbens leaves on urinary calcium and magnesium excretion rate (mg/24 h) of different groups of rat.
Days Group I Group II Group III Group IV Group V
Calcium (mg/24 h)
0 0.06 ± 0.005b*** 0.18 ± 0.0a*** 0.11 ± 0.01a*b*** 0.06 ± 003b*** 0.04 ± 0.004b***
7 0.22 ± 0.004b* 0.17 ± 0.01a* 0.22 ± 0.02b* 0.03 ± 0.005a***b*** 0.02 ± 0.005a***b***
14 0.16 ± 0.003b* 0.24 ± 0.03a* 0.34 ± 0.03a***b** 0.02 ± 0.004a***b*** 0.03 ± 0.004a***b***
21 0.14 ± 0.005b* 0.09 ± 0.01a* 0.30 ± 0.02a***b*** 0.02 ± 0.004a***b*** 0.02 ± 0.003a***b***
Magnesium (mg/24 h)
0 0.33 ± 0.05b*** 0.77 ± 0.06a*** 0.86 ± 0.05a*** 0.05 ± 0.002a***b*** 0.03 ± 0.003a***b***
7 1.29 ± 0.004b*** 0.17 ± 0.008a*** 0.22 ± 0.02a***b* 0.03 ± 0.005a***b*** 0.03 ± 0.005a***b***
14 0.79 ± 0.04b** 0.52 ± 0.06a** 0.94 ± 0.07b*** 0.24 ± 0.02a***b** 0.43 ± 0.01a***
21 0.54 ± 0.01b** 0.34 ± 0.03a** 0.69 ± 0.08b*** 0.23 ± 0.02a*** 0.34 ± 0.03a***
Values are expressed in mg/24 h urine sample as mean ± SEM. One-way Analysis of Variance (ANOVA) followed by multiple comparison Dunnett test.
Number  of animals (N) = 6. Group I: Vehicle control, Group II: EG group, Group III: Cystone group, Group IV: 150 mg/kg MELP treatment group, Group V:
300  mg/kg MELP treatment group. Comparisons are made against Group I (vehicle control)a and Group II (lithiatic control)b.
* p < 0.05.
T
E
V
N
3
T
E
V
c
t** p < 0.01.
*** p < 0.001.
able A3
ffect of methanolic extract of Launaea procumbens leaves on urinary oxalate, phosphate and uric acid excretion rate (mg/24 h) on different groups of rat.
Days Group I Group  II Group  III Group IV Group V
Oxlate (mg/24 h)
0 0.56 ± 0.11 0.42 ± 0.04 0.18 ± 0.03a***b* 0.30 ± 0.01a* 0.38 ± 0.03
7  0.67 ± 0.17b*** 1.09 ± 0.03a*** 0.63 ± 0.05b*** 0.46 ± 0.06a**b*** 0.80 ± 0.04b***
14 0.32 ± 0.05b*** 1.63 ± 0.16a*** 1.20 ± 0.06a***b** 1.38 ± 0.04a*** 1.37 ± 0.03a***
21 0.20 ± 0.04b*** 2.05 ± 0.16a*** 1.26 ± 0.07a***b*** 1.38 ± 0.04a***b*** 1.55 ± 0.05a***b**
Phosphate (mg/24 h)
0 0.15 ± 0.08 0.2 ± 0.02 0.19 ± 0.02 1.30 ± 0.02a***b*** 0.75 ± 0.11a***b***
7 0.24 ± 0.05 0.35 ± 0.04 0.25 ± 0.02 1.34 ± 0.04a***b*** 0.81 ± 0.05a***b***
14 0.16 ± 0.03b** 0.55 ± 0.08a** 0.28 ± 0.03 1.45 ± 0.05a***b*** 1.35 ± 0.15a***b***
21 0.15 ± 0.01b** 0.58 ± 0.07 a** 0.32 ± 0.01 1.53 ± 0.05a***b*** 1.42 ± 0.15 a***b***
Uric acid (mg/24 h)
0 0.11 ± 0.02b*** 0.40 ± 0.06a*** 0.41 ± 0.02a*** 0.29 ± 0.02a** 0.31 ± 0.02a**
7 0.45 ± 0.1 0.71 ± 0.06 0.43 ± 0.01 0.46 ± 0.03 1.06 ± 0.17a**b*
14 0.36 ± 0.05b*** 1.36 ± 0.15a*** 0.77 ± 0.08a* 1.27 ± 0.10 a***b*** 1.38 ± 0.02a***
21 0.31 ± 0.01b*** 1.42 ± 0.09a**** 0.77 ± 0.06a***b*** 1.58 ± 0.09 a*** 1.50 ± 0.02a***
alues are expressed in mg/24 h urine sample as mean ± SEM. One-way Analysis of Variance (ANOVA) followed by multiple comparison Dunnett test.
umber  of animals (N) = 6. Group I: Vehicle control, Group II: EG group, Group III: Cystone group, Group IV: 150 mg/kg MELP treatment group, Group V:
00  mg/kg MELP treatment group. Comparisons are made against Group I (vehicle control)a and Group II (lithiatic control)b.
* p < 0.05.
** p < 0.01.
*** p < 0.001.
able A4
ffect of methanolic extract of Launaea procumbens leaves on serum and kidney parameters on different groups of rat.
Parameter Group I Group II Group III Group IV Group V
Kidney (mg/g)
Calcium 0.11 ± 0.01b** 0.65 ± 0.22a** 0.16 ± 0.05b** 0.35 ± 0.02 0.32 ± 0.03
%  Lipid peroxidation 24.43 ± 1.43b*** 100 ± 0.00a*** 45.22 ± 2.77a***b*** 69.00 ± 3.87a***b*** 59.07 ± 4.38a***b***
Serum (mg/dl)
Creatinine 0.91 ± 0.02b*** 1.87 ± 0.04a*** 1.38 ± 0.02a***b*** 1.87 ± 0.08a*** 1.12 ± 0.09b***
Uric acid 3.23 ± 0.58b*** 8.50 ± 0.55a*** 5.77 ± 0.75a**b** 2.52 ± 0.28b*** 1.49 ± 0.24b***
alues are expressed in mg/g in kidney parameter and mg/dl in serum sample as mean ± SEM. One-way Analysis of Variance (ANOVA) followed by multiple
omparison  Dunnett test. Number of animals (N) = 6. Group I: Vehicle control, Group II: EG group, Group III: Cystone group, Group IV: 150 mg/kg MELP
reatment  group, Group V: 300 mg/kg MELP treatment group. Comparisons are m
** p < 0.01.
*** p < 0.001.ade against Group I (vehicle control)a and Group II (lithiatic control)b.
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Table A5
Effect  of methanolic extract of Launaea procumbens leaves on urinary total protein excretion rate (mg/24 h) on different groups of rat.
Days Group I Group II Group III Group IV Group V
0 0.21 ± 0.01 0.93 ± 0.06a** 0.87 ± 0.06a** 0.96 ± 0.19a*** 0.77 ± 0.17a*
7 1.19 ± 0.03b*** 1.85 ± 0.06a** 0.96 ± 0.07b*** 1.52 ± 0.11 1.30 ± 0.14b***
14 0.67 ± 0.04b** 3.33 ± 0.34a*** 1.14 ± 0.06a*** 1.60 ± 0.12 0.78 ± 0.25a**
21 0.75 ± 0.11b*** 3.66 ± 0.24a*** 2.60 ± 0.16a***b*** 3.01 ± 0.20a***b* 4.58 ± 0.06a***b**
Values are expressed in mg/24 h urine sample as mean ± SEM (n = 6). One-way Analysis of Variance (ANOVA) followed by multiple comparison Dunnett test.
Group  I: Vehicle control, Group II: EG group, Group III: Cystone group, Group IV: 150 mg/kg MELP treatment group, Group V: 300 mg/kg MELP treatment
group.  Comparisons are made against Group I (vehicle control)a and Group II (lithiatic control)b.
* p < 0.05.
** p < 0.01.
*** p < 0.001.
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